Group 1: Ruijie Networks - Ruijie Networks reported that its data center product revenue growth in the first half of the year was primarily driven by internet clients, accounting for over 90% of revenue, with 400G products making up over 60% [1] - The demand for cloud computing infrastructure remains strong, with expected increased capital expenditure from the internet industry based on intelligent computing [1] - The company’s overseas revenue reached 1.145 billion yuan, a year-on-year increase of 48%, primarily targeting the SMB market, with the number of partners growing to 2,620 [1] Group 2: Baillie Gifford - Baillie Gifford is collaborating with BMS to develop iza-bren and has initiated three key overseas clinical trials for treating triple-negative breast cancer, EGFR-mutant non-small cell lung cancer, and urothelial carcinoma [2] - The company has nine DC drugs in clinical trials and one in the IND acceptance stage, with R&D expenses amounting to 1.038 billion yuan as of June 30 [2] - The company aims to become a leading entry-level multinational corporation in the oncology treatment field within five years [2] Group 3: Weiming Environmental - Weiming Environmental achieved revenue of 1.711 billion yuan from environmental project operations in the first half, an increase of 100 million yuan year-on-year, while equipment manufacturing revenue decreased by 300 million yuan to 2.175 billion yuan [3] - The company’s environmental operation business saw an increase in gross margin due to higher waste processing volumes and improved operational efficiency [3] - The company has received over 50 million yuan in national subsidies and is optimistic about the second half of the year [3]
【机构调研记录】睿远基金调研锐捷网络、百利天恒等3只个股(附名单)